PACE

PACE launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health

1 October 2025 -- Alderley Park, UK -- To stay ahead of the escalating antibiotic resistance crisis, we need bold thinking and transformative innovation. According to the World Health Organization (WHO), over 80% of recently approved bacterial antimicrobial agents show similarities to existing drug classes, meaning their potential is limited as resistance mechanisms to these...

New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation 

Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050  19 October 2023 – Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30m initiative supporting early-stage innovation against...